In episode 7 of "EHA Unplugged", Prof. Shaun McCann describes the clinical and genetic features of chronic myeloid leukemia (CML), discusses the best therapeutic options, and characterizes the changes that occur in the natural history of the disease after the introduction of tyrosine-kinase inhibitors (TKIs).
Subscribe to your favorite podcasts and get free AI summaries within minutes of release.
Browse trending podcasts or search for your favorites
One click to follow any show — always free, no credit card
Free AI summaries delivered by email within minutes of release
Free forever · No credit card · Unsubscribe anytime
Never miss an episode of EHA Unplugged. Subscribe for free →
No transcript available.
